These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1364847)

  • 1. Modification of the rat uterine response to oestrogen and tamoxifen by thromboxane antagonists.
    Kerr MB; Marshall K; Senior J
    Br J Pharmacol; 1991 Mar; 102(3):742-6. PubMed ID: 1364847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of thromboxane receptor antagonists on oestrogen-induced uterotrophic responses in the spontaneously hypertensive rat.
    Kerr MB; Marshall K; Senior J
    Br J Pharmacol; 1991 Jun; 103(2):1363-6. PubMed ID: 1832065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of thromboxane in the uterotrophic response in the gravid normotensive and spontaneously hypertensive rat.
    Kerr MB; Marshall K; Senior J
    J Endocrinol; 1992 Nov; 135(2):257-61. PubMed ID: 1474332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of mepyramine and ranitidine on the oestrogen and anti-oestrogen stimulated rat uterus.
    Marshall K; Senior J
    Br J Pharmacol; 1986 Sep; 89(1):251-6. PubMed ID: 3801774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a single dose of oestradiol on tamoxifen-induced uterine hyperaemia and growth in the rat.
    Marshall K; Senior J
    Br J Pharmacol; 1989 Oct; 98(2):383-8. PubMed ID: 2819325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study on the effect of a single dose of tamoxifen on uterine hyperaemia and growth in the rat.
    Marshall K; Senior J
    Br J Pharmacol; 1987 Oct; 92(2):429-35. PubMed ID: 3676603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-oestrogen modification of uterine responses to oestrogen in the rat.
    Majid E; Senior J
    J Reprod Fertil; 1982 Sep; 66(1):79-85. PubMed ID: 7120203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the subcellular distribution of the rat uterus oestrogen receptor as induced by oestradiol, tamoxifen and ZD 182,780.
    Mendes AF; Caramona MM; Lopes MC
    J Pharm Pharmacol; 1996 Mar; 48(3):302-5. PubMed ID: 8737058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of contraction-mediating prostanoid receptors in human hand veins: effects of the thromboxane receptor antagonists BM13,505 and AH23848.
    Arner M; Högestätt ED; Uski TK
    Acta Physiol Scand; 1991 Jan; 141(1):79-86. PubMed ID: 2053448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-related effects of non-steroidal antioestrogens nad oestrogens on the measurement of cytoplasmic oestrogen receptors in the rat and mouse uterus.
    Jordan VC; Rowsby L; Dix CJ; Prestwich G
    J Endocrinol; 1978 Jul; 78(1):71-81. PubMed ID: 681874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor I gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182780.
    Huynh HT; Pollak M
    Cancer Res; 1993 Dec; 53(23):5585-8. PubMed ID: 8242606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ornithine decarboxylase inhibition and the uterotrophic response to oestrogen in rats.
    Marshall K; Senior J
    J Reprod Fertil; 1986 Mar; 76(2):597-601. PubMed ID: 3084768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterotrophic actions of estradiol and tamoxifen are associated with inhibition of uterine insulin-like growth factor binding protein 3 gene expression.
    Huynh H; Pollak M
    Cancer Res; 1994 Jun; 54(12):3115-9. PubMed ID: 7515764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the metabolic activation of non-steroidal antioestrogens: a study of structure-activity relationships.
    Allen KE; Clark ER; Jordan VC
    Br J Pharmacol; 1980; 71(1):83-91. PubMed ID: 7470748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The binding of [3H]-oestradiol-17 beta in the immature rat uterus during the sequential administration of non-steroidal anti-oestrogens.
    Jordan VC; Naylor KE
    Br J Pharmacol; 1979 Feb; 65(2):167-73. PubMed ID: 760895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcellular effects of monohydroxytamoxifen in the rat uterus: steroid receptors and mitosis.
    Dix CJ; Jordan VC
    J Endocrinol; 1980 Jun; 85(3):393-404. PubMed ID: 7411007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential for a novel pure anti-oestrogen.
    Wakeling AE
    Horm Res; 1989; 32 Suppl 1():257-9; discussion 260. PubMed ID: 2613211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity.
    Jordan VC; Collins MM; Rowsby L; Prestwich G
    J Endocrinol; 1977 Nov; 75(2):305-16. PubMed ID: 591813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth inhibitory effects of thromboxane antagonists on breast cancer cell lines: a preliminary study.
    Marshall K; Lane K; Senior J
    Adv Exp Med Biol; 1997; 400A():455-60. PubMed ID: 9547590
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the biological effects of tamoxifen and a new antioestrogen (LY 117018) on the immature rat uterus.
    Wakeling AE; O'Connor KM; Newboult E
    J Endocrinol; 1983 Dec; 99(3):447-53. PubMed ID: 6644235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.